Analyst Ratings for Immuneering Corporation (IMRX)
IMRX Rating Summary
IMRX Price Target Summary
- Highest: $30.00 (Oppenheimer)
- Lowest: $11.00 (Needham)
- Average: $16.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$16.00 (+244.8%)
* Over Last 12-Mos
Rating Score: 6.4 / 10
Percentile Rank: 67%
Avg. $ Target:
$16.00 (+244.8%)
* Over Last 12-Mos
Rating Score: 6.4 / 10
Percentile Rank: 67%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/8/2026 | Cantor Fitzgerald | Li Watsek | New Coverage | Overweight (N/A) |
N/A (N/A) |
5.10 (4.64) |
-9.02% | Details |
| 10/31/2025 | Leerink | Andrew Berens | New Coverage | Outperform (N/A) |
15.00 (N/A) |
6.41 (4.64) |
-27.61% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
